# India Nutraceutical Market Size, Share & Forecast, By Product Type, Application & Distribution Channel, 2026-2031 --- ## Market Overview # CHAPTER 1 - Market Overview The India Nutraceutical Market operates across functional foods, functional beverages and concentrated dietary supplements sold through grocery, pharmacy, specialty-wellness and digital channels. Functional foods represented **37.6% of sector revenue in 2024**, reflecting the commercial importance of products that integrate added proteins, probiotics, vitamins, minerals and botanical ingredients into habitual consumption rather than requiring a separate supplementation routine. West India is the principal commercial hub because Maharashtra and Gujarat combine pharmaceutical formulation capabilities, contract manufacturing, ingredient processing, modern retail and large urban consumer bases. Grocery stores accounted for **40.3% of functional-food sales in 2024**, making proximity to metropolitan distribution networks, organized retail warehouses and pharmacy chains strategically important for reducing replenishment times and supporting national product launches. Market access is governed by the Food Safety and Standards framework, which covers **eight functional-food categories**, including health supplements, nutraceuticals, food for special dietary use, food for special medical purpose and probiotic products. Labels cannot claim to prevent, treat or cure disease, requiring companies to invest in compliant claims, substantiation, ingredient approvals and quality documentation before commercial scaling. India is transitioning from a primarily domestic wellness market toward an ingredient, formulation and branded-product export platform. Processed-food exports reached **USD 10.09 Bn in FY2024-25**, while food processing attracted approximately **USD 7.21 Bn of foreign direct investment during the decade ending FY2024-25**. Standardized trade codes, manufacturing incentives and stronger export certification can improve realization and international buyer access. ## KPIs at a Glance * Market Value: USD 34,500 million (2025) * Dominant Region: West India (2025) * Dominant Segment: Dietary Supplements (fastest growing) * Total Number of Players: 3,500+ ## Future Outlook The India Nutraceutical Market is projected to expand from USD 34,500 Mn in 2025 to USD 67,733 Mn by 2031, representing an 11.90% forecast CAGR. This follows a 14.02% historical CAGR between 2020 and 2025, when preventive health, immunity products, fortified staples and sports nutrition broadened consumer participation. Growth is expected to normalize from pandemic-era peaks but remain structurally above conventional packaged-food growth. Functional foods will preserve the largest revenue base, while dietary supplements will gain from targeted health positioning, practitioner influence and recurring monthly consumption among fitness, metabolic-health, women’s-health and healthy-aging cohorts. Forecast value creation will increasingly depend on product mix, scientific substantiation and route-to-market economics rather than category expansion alone. Online dietary-supplement sales are expected to grow at approximately 15.0% annually through 2030, enabling brands to improve consumer data capture, subscription retention and niche-product availability. Premiumization, microencapsulation, probiotics, plant proteins and personalized formulations will raise average selling prices, while marketplaces and quick-commerce channels compress discovery cycles. Downside risks include non-compliant claims, inconsistent ingredient quality and customer-acquisition inflation. Companies combining compliant innovation, omnichannel distribution and domestic manufacturing should capture a disproportionate share of incremental profit pools. --- | | | | --- | --- | | **11.90%** Forecast CAGR | **$67,733 Mn** 2031 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2026-2031** | Historical CAGR **14.02%** | --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** India * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2026-2031 * **Market Segments Covered:** 7 primary segmentation dimensions (Product Type, Application, End User, Technology, Price Tier, Distribution Channel, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn/Bn ### Segmentation Data Tree * Product Type + Functional Foods - Fortified dairy and cereals - Protein snacks and nutrition bars - Probiotic and high-fiber foods + Functional Beverages - Energy and performance drinks - Fortified hydration beverages - Probiotic and botanical drinks + Dietary Supplements - Vitamins and minerals - Herbal and botanical supplements - Protein, amino acid and sports supplements * Application + General Wellness and Immunity - Daily micronutrient support - Immune-function formulations + Digestive Health - Probiotic and prebiotic support - Fiber and digestive-enzyme products + Metabolic and Cardiovascular Health - Blood-glucose management - Heart health and lipid support + Bone and Joint Health - Calcium and vitamin D formulations - Mobility and joint-support products + Cognitive and Stress Support - Sleep and relaxation products - Focus and cognitive-performance products * End User + Adults - General working-age consumers - Condition-specific wellness users + Children and Adolescents - Pediatric growth nutrition - School-age immunity support + Older Adults - Healthy-aging consumers - Clinical and mobility-support users + Athletes and Fitness Consumers - Professional and competitive athletes - Recreational fitness consumers + Pregnant and Lactating Women - Prenatal nutrition users - Postnatal and lactation-support users * Technology + Botanical Extraction - Water and solvent extraction - Standardized phytochemical extraction + Fermentation and Probiotic Culturing - Microbial strain fermentation - Probiotic stabilization + Microencapsulation - Controlled-release ingredients - Taste and stability masking + Liposomal Delivery - Lipid-based vitamin delivery - Enhanced-bioavailability formulations + Precision Nutrition Formulation - Biomarker-informed products - Algorithm-led personalization * Price Tier + Mass Market - Entry-price daily nutrition - High-volume fortified products + Mid-Premium - Branded condition-specific nutrition - Enhanced ingredient formulations + Premium - Imported and patented ingredients - Clean-label specialized products + Clinical Premium - Practitioner-recommended formulations - Medical-nutrition products * Distribution Channel + Pharmacies and Drug Stores - Independent pharmacies - National and regional pharmacy chains + Grocery and Modern Trade - Supermarkets and hypermarkets - Convenience and neighborhood stores + Brand Direct E-Commerce - Brand websites and applications - Subscription and replenishment programs + Online Marketplaces - General e-commerce marketplaces - Health and pharmacy platforms + Specialty Wellness Stores - Sports-nutrition retailers - Organic and natural-product stores * Geography + West India - Maharashtra and Goa - Gujarat and Rajasthan + North India - Delhi NCR and Haryana - Punjab, Uttar Pradesh and Uttarakhand + South India - Karnataka and Telangana - Tamil Nadu, Kerala and Andhra Pradesh + East and Northeast India - West Bengal, Odisha and Bihar - Northeastern states --- ## Market Trajectory # India Nutraceutical Market Size, Share & Forecast, By Product Type, Application & Distribution Channel, 2026-2031 **Geography:** India | **Historical Period:** 2020-2025 | **Forecast Period:** 2026-2031 The India Nutraceutical Market reached an estimated **USD 34,500 Mn in 2025**, supported by preventive-health expenditure, product fortification, digital distribution and demand from an estimated **107.98 million residents aged 65 years and above**. Functional foods remain the largest revenue pool, while dietary supplements and online channels provide the strongest growth opportunities. ## Report Metadata Summary | | | | --- | --- | | **Base Year** | 2025 | | **CAGR for Past 5 Years** | 14.02% | | **Historical Period** | 2020-2025 | | **Forecast Period** | 2026-2031 | | **Forecast Period CAGR** | 11.90% | # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. ### Historical and Projected Market Size | Year | Market Size (USD Mn) | Status | | --- | --- | --- | | 2020 | 17,900 | Historical | | 2021 | 20,250 | Historical | | 2022 | 23,100 | Historical | | 2023 | 26,600 | Historical | | 2024 | 30,370 | Historical | | 2025 | 34,500 | Base Year | | 2026F | 38,606 | Forecast | | 2027F | 43,200 | Forecast | | 2028F | 48,340 | Forecast | | 2029F | 54,093 | Forecast | | 2030F | 60,530 | Forecast | | 2031F | 67,733 | Forecast | ### YoY Growth Rate | Year | YoY Growth (%) | Primary Growth Context | | --- | --- | --- | | 2021 | 13.1% | Immunity and preventive-health demand | | 2022 | 14.1% | Retail reopening and repeat supplement use | | 2023 | 15.2% | Sports nutrition and D2C expansion | | 2024 | 14.2% | Functional-food penetration and premiumization | | 2025 | 13.6% | Broader omnichannel availability | | 2026F | 11.9% | Normalization with sustained penetration | | 2027F | 11.9% | Personalized and condition-specific products | | 2028F | 11.9% | Tier 2 and Tier 3 distribution scaling | | 2029F | 11.9% | Premium ingredient and clinical nutrition mix | | 2030F | 11.9% | Export and domestic manufacturing expansion | | 2031F | 11.9% | Recurring wellness consumption | ### Market Value vs Volume Growth | Year | Market Value Growth (%) | Standardized Volume Growth (%) | Price and Mix Contribution (Percentage Points) | | --- | --- | --- | --- | | 2020 | - | - | - | | 2021 | 13.1% | 11.2% | 1.9 | | 2022 | 14.1% | 9.7% | 4.4 | | 2023 | 15.2% | 10.2% | 5.0 | | 2024 | 14.2% | 9.5% | 4.7 | | 2025 | 13.6% | 8.7% | 4.9 | | 2026F | 11.9% | 9.1% | 2.8 | | 2027F | 11.9% | 9.1% | 2.8 | | 2028F | 11.9% | 9.1% | 2.8 | | 2029F | 11.9% | 9.1% | 2.8 | | 2030F | 11.9% | 9.1% | 2.8 | ### Historical Market Performance (2020-2025) Market growth reached its historical peak of 15.2% in 2023 as fitness nutrition, immunity products, fortified foods and online-first wellness brands converted pandemic-driven trial into repeat consumption. Standardized retail volume expanded from approximately 2,500 million consumer-equivalent packs in 2020 to 4,000 million in 2025. The implied average value per pack increased from USD 7.16 to USD 8.62, reflecting premium ingredients, higher protein content, condition-specific positioning and a shift from basic vitamins toward probiotics, botanicals and combination formulations. Functional foods remained the largest product category, but supplements generated stronger incremental growth. ### Forecast Market Outlook (2026-2031) The market is forecast to sustain an 11.90% CAGR through 2031, with annual growth stabilizing as category penetration deepens beyond metropolitan consumers. Standardized volume is projected to reach approximately 6,745 million packs, equivalent to a 9.1% volume CAGR from 2025. Average value per pack is expected to rise to USD 10.04, supported by premiumization and scientifically differentiated products. Growth will concentrate in dietary supplements, personalized nutrition, healthy-aging formulations and direct digital channels. Regulatory compliance, substantiated claims and efficient customer retention will become stronger determinants of profitability than broad product proliferation. --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The India Nutraceutical Market combines high-volume functional consumption with rapidly expanding targeted supplementation. For CEOs and investors, the trajectory indicates that distribution productivity, repeat purchase and price-mix management will determine whether revenue growth converts into sustainable operating returns. | Year | Market Size (USD Mn) | YoY Growth (%) | Standardized Retail Volume (Mn Packs) | ASP (USD per Pack) | Online Channel Share, Modelled (%) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 17,900 | - | 2,500 | 7.16 | 8% | Historical | | 2021 | 20,250 | 13.1% | 2,780 | 7.28 | 10% | Historical | | 2022 | 23,100 | 14.1% | 3,050 | 7.57 | 13% | Historical | | 2023 | 26,600 | 15.2% | 3,360 | 7.92 | 17% | Historical | | 2024 | 30,370 | 14.2% | 3,680 | 8.25 | 21% | Historical | | 2025 | 34,500 | 13.6% | 4,000 | 8.62 | 25% | Base Year | | 2026 | 38,606 | 11.9% | 4,364 | 8.85 | 29% | Forecast and Latest Operating KPIs | | 2027 | 43,200 | 11.9% | 4,761 | 9.07 | 32% | Forecast and Industry Outlook | | 2028 | 48,340 | 11.9% | 5,194 | 9.31 | 35% | Forecast and Industry Outlook | | 2029 | 54,093 | 11.9% | 5,667 | 9.55 | 38% | Forecast and Industry Outlook | | 2030 | 60,530 | 11.9% | 6,183 | 9.79 | 41% | Forecast and Industry Outlook | | 2031 | 67,733 | 11.9% | 6,745 | 10.04 | 44% | Forecast and Industry Outlook | **KPI 1, Standardized Retail Volume:** **4,000 million consumer-equivalent packs, 2025, India**. Scale supports manufacturing utilization but raises forecasting and inventory complexity across short-shelf-life beverages and long-shelf-life supplements. India had approximately 107.98 million residents aged 65 and above in 2025, expanding the addressable base for recurring healthy-aging nutrition. **KPI 2, Average Selling Price:** **USD 8.62 per standardized pack, 2025, India**. Future margin growth depends on premium mix and formulation defensibility rather than price inflation alone. Gujarat nutraceutical sales increased 42.7% between January 2022 and January 2026, while mineral-supplement sales rose 80.2%, indicating willingness to allocate recurring spend to targeted products. **KPI 3, Online Channel Share:** **25% modelled share, 2025, India**. Digital channels improve assortment visibility and consumer data capture but expose brands to acquisition-cost inflation and marketplace discounting. Online dietary-supplement sales are projected to grow at approximately 15.0% annually from 2025 to 2030, exceeding broader category growth. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Product Type | **Fastest Growing Segment:** Distribution Channel | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Product Type | Functional Foods; Functional Beverages; Dietary Supplements | | 2 | Application | General Wellness and Immunity; Digestive Health; Metabolic and Cardiovascular Health; Bone and Joint Health; Cognitive and Stress Support | | 3 | End User | Adults; Children and Adolescents; Older Adults; Athletes and Fitness Consumers; Pregnant and Lactating Women | | 4 | Technology | Botanical Extraction; Fermentation and Probiotic Culturing; Microencapsulation; Liposomal Delivery; Precision Nutrition Formulation | | 5 | Price Tier | Mass Market; Mid-Premium; Premium; Clinical Premium | | 6 | Distribution Channel | Pharmacies and Drug Stores; Grocery and Modern Trade; Brand Direct E-Commerce; Online Marketplaces; Specialty Wellness Stores | | 7 | Geography | West India; North India; South India; East and Northeast India | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Product Type** - Product type is the dominant commercial dimension because consumption frequency, gross margin, claims architecture and channel economics differ materially across functional foods, beverages and supplements. Functional foods hold the largest revenue pool because they are integrated into routine diets, while dietary supplements provide stronger unit margins, more targeted health positioning and faster growth through recurring monthly regimens. **Distribution Channel** - Distribution channel is the fastest-growing dimension as brand-direct platforms, online marketplaces and digital pharmacies expand access beyond large metropolitan retail networks. Online dietary supplements are the leading sub-segment because broad assortment, content-led education, subscriptions and customer-level data improve product discovery and replenishment. Winners must balance digital reach with pharmacy credibility and modern-trade scale. --- ## Regional Analysis # CHAPTER 6 - Regional Analysis India ranks behind China but ahead of Japan, South Korea and Indonesia among selected Asian nutraceutical peers by 2025 market value. Its advantage combines a large consumer base, rapid digital distribution and substantial botanical and formulation capabilities, while per-capita category spending remains below mature East Asian markets. ### KPI Summary * Focus Country Ranking: **2nd** * Focus Country Market Size: **USD 34,500 Mn** * Focus Country CAGR (2026-2031): **11.90%** | Country | Market Size, 2025 | CAGR, Forecast Period (%) | Adult Diabetes Prevalence, 2024 (%) | Dedicated Health-Food Framework, Reference Year | | --- | --- | --- | --- | --- | | India | USD 34,500 Mn | 11.90% | 10.5% | 2016 | | China | USD 98,230 Mn | 8.60% | 11.9% | 2016 | | Japan | USD 23,900 Mn | 6.35% | 11.6% | 1991 | | South Korea | USD 13,620 Mn | 9.10% | 9.8% | 2002 | | Indonesia | USD 8,620 Mn | 7.70% | 11.3% | 2019 | ### Market Position India ranks second among the selected peers with a 2025 value of USD 34,500 Mn, supported by broad functional-food consumption and an addressable adult diabetes population of approximately 89.8 million. ### Growth Advantage India's 11.90% forecast CAGR exceeds China's 8.60%, South Korea's 9.10% and Japan's 6.35%, positioning India as the peer group's growth leader despite lower per-capita category expenditure. ### Competitive Strengths India combines 107.98 million people aged 65+, more than USD 1 Bn of nutraceutical-ingredient exports and a food-processing incentive framework equivalent to approximately USD 1.3 Bn. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the India Nutraceutical Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. ## Growth Drivers ### Preventive Health and Chronic-Disease Management India's **89.8 million adults with diabetes (2024, India)** are accelerating demand for metabolic, cardiovascular and daily wellness formulations. * **10.5% adult diabetes prevalence (2024, India)** expands the addressable cohort for low-sugar foods, fiber, proteins, omega fatty acids and condition-specific supplements, benefiting compliant brands with clinically coherent positioning. * **49.1% of deaths attributed to noncommunicable diseases (2021, India)** reinforces consumer and institutional interest in prevention, creating opportunities for nutrition companies that avoid therapeutic claims while demonstrating measurable wellness benefits. * **107.98 million people aged 65 and above (2025, India)** create recurring demand for bone, muscle, cognition, heart and digestive-health products, supporting subscription models and practitioner-led channels. ### Digital Commerce and Consumer Education Online supplement sales are projected to grow at **15.0% annually (2025-2030, India)**, increasing assortment access and direct customer engagement. * **502 nutraceutical-technology startups (2026, India)** indicate strong experimentation in personalized nutrition, gummies, plant proteins, gut health and digital diagnostics, expanding strategic acquisition and partnership options. * **25% modelled online market share (2025, India)** enables brands to collect first-party data, test formulations and operate subscription programs, although customer lifetime value must exceed rising digital acquisition costs. * **40.3% grocery-channel share for functional foods (2024, India)** demonstrates that digital growth complements rather than replaces physical retail, favoring omnichannel operators with consistent pricing and inventory. ### Ingredient and Delivery-Format Innovation Probiotic ingredients held **24.66% of ingredient revenue (2024, India)**, demonstrating demand for differentiated digestive and immunity formulations. * **13.5% projected vitamin-ingredient CAGR (2025-2030, India)** supports investment in domestic premixes, stability testing and fortified consumer products, particularly for vitamins C, D and B-complex. * **13.9% projected dietary-supplement CAGR (2025-2030, India)** rewards companies that combine scientific claims, convenient dosage formats and targeted applications rather than competing solely on generic multivitamins. * **37.6% functional-food revenue share (2024, India)** creates monetization opportunities for food manufacturers using fortification, proteins, probiotics and fiber to raise realization within established consumption occasions. --- ## Market Challenges ### Claims, Ingredient and Licensing Complexity The regulatory framework covers **eight functional-food categories (current framework, India)**, increasing classification, claims and documentation requirements. * **Zero permitted disease-cure claims for health supplements (current framework, India)** limits pharmaceutical-style marketing and requires investment in compliant structure-function language, substantiation and consumer education. * **Thirty years of safe use in the origin country or fifteen years in India** may be required for incident-free-history ingredient submissions, increasing timelines for novel botanical commercialization. * **Eight regulated product classifications** can create boundary disputes between ordinary foods, supplements, special dietary foods and medical-purpose nutrition, affecting licensing route, labeling and launch timing. ### Quality Consistency and Consumer Trust A market containing **502 tracked nutraceutical-technology startups (2026, India)** creates innovation but also uneven quality and claims maturity. * **Minus 10.0% permitted nutrient-value variation in specified circumstances (2024 regulation, India)** highlights the technical importance of assay validation, stability and manufacturing controls across shelf life. * **24.66% probiotic ingredient share (2024, India)** raises strain-identity, viability and cold-chain questions, making accredited testing and validated packaging critical to brand trust. * **106 tracked nutraceutical startups within the active innovation universe (2026, India)** intensify product proliferation, requiring retailers and investors to differentiate evidence-backed products from marketing-led formulations. ### Affordability and Uneven Category Penetration India's estimated **USD 24 annual nutraceutical spend per resident (2025, India)** remains substantially below mature Asian benchmarks. * **Approximately USD 24 per-capita category value (2025, India)** indicates a large penetration runway but limits immediate uptake of imported, patented and clinical-premium products outside affluent cohorts. * **Approximately USD 194 per-capita category value (2025, Japan)** illustrates the gap between India's scale-led market and a mature high-frequency health-food market, requiring localized pack sizes and pricing. * **Mass-market products account for an estimated majority of Indian consumption (2025, India)**, pressuring manufacturers to balance affordability with testing, ingredient standardization, channel margins and brand investment. --- ## Market Opportunities ### Personalized Nutrition and Subscription Commerce Digital channels growing at **15.0% annually (2025-2030, India)** can convert condition-specific nutrition into recurring subscription revenue. * **502 nutraceutical-technology startups (2026, India)** provide investment targets across diagnostics, algorithm-led recommendations, microbiome health and convenient delivery formats. * **25% modelled digital-channel share (2025, India)** benefits brand owners, marketplaces and contract manufacturers that can support rapid product testing and replenishment programs. * **15.0% online growth through 2030** will require better consent management, evidence-based recommendations, interoperable health data and retention economics to translate consumer acquisition into durable margins. ### Export-Oriented Ingredients and Contract Manufacturing India exports more than **USD 1 Bn of nutraceutical ingredients (2025 reference, India)**, creating a scalable business-to-business growth platform. * **USD 10.09 Bn processed-food exports (FY2024-25, India)** provide logistics, certification and buyer-network infrastructure that nutraceutical companies can leverage for botanical extracts, premixes and finished formulations. * **Approximately USD 1.3 Bn equivalent food-processing incentive outlay** benefits manufacturers investing in scale, branding and export-market development. * **More than USD 1 Bn ingredient exports** can expand if companies strengthen internationally accepted testing, traceability, novel-food dossiers and market-specific claims compliance. ### Healthy-Aging and Metabolic Nutrition A combined base of **107.98 million older residents and 89.8 million adults with diabetes** supports specialized recurring nutrition. * **107.98 million people aged 65+ (2025, India)** create monetizable demand for muscle, bone, cognition, digestion and cardiovascular nutrition through pharmacies, hospitals and home-care ecosystems. * **89.8 million adults with diabetes (2024, India)** benefit manufacturers, clinicians, pharmacies and insurers developing compliant low-sugar and metabolic-support product pathways. * **10.5% diabetes prevalence (2024, India)** requires stronger clinical evidence, practitioner education and responsible claims before specialized nutrition can move from discretionary wellness into structured care pathways. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview The market is fragmented across multinational nutrition companies, diversified consumer-health groups, Ayurvedic brands and digital-native specialists, with regulatory credibility, distribution reach and repeat-purchase economics creating the principal entry barriers. * **Key players:** 10 * **New Entrants (last 5 yrs):** 106 ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Amway India Enterprises Pvt Ltd | - | Gurugram, India | 1995 | Vitamins, minerals, botanicals and protein supplements under Nutrilite | | Herbalife India Pvt Ltd | - | Bengaluru, India | 1999 | Weight management, protein nutrition and active-lifestyle supplements | | Abbott India Ltd | - | Mumbai, India | 1944 | Adult, pediatric and condition-specific nutrition products | | Himalaya Wellness Company | - | Bengaluru, India | 1930 | Herbal supplements, botanical wellness and personal nutrition | | Dabur India Ltd | - | Ghaziabad, India | 1884 | Ayurvedic health supplements, functional foods and herbal wellness | | Patanjali Ayurved Ltd | - | Haridwar, India | 2006 | Ayurvedic supplements, functional foods and mass-market wellness | | Bright Lifecare Pvt Ltd (HealthKart) | - | Gurugram, India | 2011 | Sports nutrition, protein supplements and omnichannel wellness retail | | Zydus Wellness Ltd | - | Ahmedabad, India | 1994 | Functional nutrition, sugar substitutes and specialized health foods | | Meyer Organics Pvt Ltd | - | Thane, India | 1982 | Vitamins, minerals and specialized nutraceutical formulations | | Baidyanath Group | - | Kolkata, India | 1917 | Ayurvedic formulations, herbal tonics and traditional wellness products | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Product Portfolio Breadth * Online and Pharmacy Distribution Reach * India Nutraceutical Revenue Growth * Gross Margin ### Analysis Covered * **Market Share Analysis:** Compares company scale across supplements, foods, beverages and channels * **Cross Comparison Matrix:** Benchmarks operational reach, product depth, growth and profitability indicators * **SWOT Analysis:** Evaluates brand, compliance, distribution, innovation and portfolio vulnerabilities systematically * **Pricing Strategy Analysis:** Assesses price ladders, pack architecture, discounts and premiumization potential * **Company Profiles:** Reviews ownership, portfolio, distribution, strategic initiatives and market positioning --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, retention, gross margin, valuations, compliance risk, exits * **Corporates:** category mix, innovation pipeline, channel productivity, pricing, acquisitions * **Government:** food safety, exports, fortification, manufacturing, consumer protection, employment * **Operators:** utilization, quality assurance, formulation, inventory, distribution, repeat purchase * **Financial institutions:** working capital, covenant strength, cash conversion, demand stability ### What You'll Gain * Market sizing and trajectory * Policy and compliance mapping * Trade exposure indicators * Segment structure and levers * Competitive landscape shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Reviewed nutraceutical regulations and amendments * Mapped functional nutrition product categories * Analyzed company filings and portfolios * Assessed health, demographic and trade indicators #### Primary Research * Interviewed nutraceutical category directors * Consulted formulation and R&D heads * Engaged pharmacy procurement managers * Surveyed nutritionists and fitness retailers #### Validation and Triangulation * Validated findings across 320 respondents * Reconciled manufacturer and channel estimates * Cross-checked prices and retail volumes * Tested category and geography consistency ### Phase 2: Market Size Estimation #### Top-Down Assessment * National functional-food and supplement expenditure * Breakdown across food, beverage and supplement categories * Government food-processing and health statistics #### Bottom-Up Modeling * Company-level nutraceutical sales and volumes * Retail pack pricing and channel margins * Standardized packs multiplied by realized ASP #### Forecasting and Scenario Analysis * Income, aging, chronic-disease and digital-adoption variables * Claims regulation, premiumization and distribution scenarios * Baseline, optimistic and constrained projections through 2031 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the India Nutraceutical Market value chain from ingredient supply and formulation through brand commercialization, distribution and end-user recommendation. * Ingredient and Premix Suppliers * Manufacturers and Brand Owners * Pharmacy, Retail and Digital Channels * Healthcare and Consumer Buyers #### Sample Size A total of 320 respondents were engaged across market segments to ensure robust representation of supply, channel and demand-side perspectives. * Ingredient and Premix Suppliers - 80 respondents (Commercial Director, Quality Assurance Head) * Manufacturers and Brand Owners - 95 respondents (Category Director, Formulation R&D Head) * Pharmacy, Retail and Digital Channels - 75 respondents (Procurement Manager, E-Commerce Category Head) * Healthcare and Consumer Buyers - 70 respondents (Clinical Nutritionist, Wellness Consumer) #### Validation and Triangulation Validation compared respondent evidence across commercial, operational, regulatory and demand-side cohorts within the India Nutraceutical Market. * Cross-segment revenue and volume consistency checks * Ingredient-to-retail value chain reconciliation * Operational and strategic respondent alignment * Pack-price and consumption sanity checks --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: What is the size of the India Nutraceutical Market in the base year? **A:** The India Nutraceutical Market was worth USD 34,500 million in 2025 under a broad retail-revenue scope covering functional foods, functional beverages and dietary supplements. The estimate is anchored to the Ministry of Food Processing Industries' 2024 sector value and adjusted for category growth, company sales, standardized retail volume and average selling prices. Functional foods remained the largest revenue pool because they are consumed through habitual food occasions, while dietary supplements contributed stronger growth and higher value per pack. **Data used:** USD 34,500 million market value in 2025; 4,000 million standardized retail packs in 2025 **So what:** Investors should evaluate sub-category economics rather than treating the market as a single homogeneous wellness pool. #### Q: How fast will the India Nutraceutical Market grow through 2031? **A:** The market is projected to reach USD 67,733 million by 2031, representing an 11.90% CAGR from the 2025 base. Growth will be supported by dietary supplements, online distribution, condition-specific nutrition, fortified foods and healthy-aging demand. Standardized retail volume is projected to grow at approximately 9.1% annually, with the remaining value expansion generated by premium ingredients, improved formulations and channel mix. The forecast assumes continued regulatory enforcement without a material restriction on compliant wellness claims. **Data used:** USD 67,733 million forecast value in 2031; 11.90% CAGR during 2026-2031 **So what:** Companies require both volume penetration and price-mix improvement to outperform the market CAGR. #### Q: Where will the market's profit pools shift during the forecast period? **A:** Profit pools will shift toward targeted supplements, probiotics, personalized nutrition, premium botanical formulations and direct digital channels. Functional foods will continue to generate the largest absolute revenue, but their grocery-led economics generally involve lower product concentration and stronger retail bargaining power. Supplements provide higher value density, subscription potential and condition-specific differentiation. Digital distribution can improve gross-to-net realization and first-party data capture, although rising advertising costs and marketplace discounts may offset these benefits for brands with weak retention. **Data used:** 13.9% dietary-supplement CAGR during 2025-2030; 15.0% online supplement-sales CAGR during 2025-2030 **So what:** Management teams should allocate capital toward evidence-backed niches with repeat purchase rather than undifferentiated product launches. #### Q: What is the most important risk facing nutraceutical companies in India? **A:** The principal risk is the combination of regulatory non-compliance and inconsistent product substantiation. FSSAI rules distinguish multiple functional-food categories and prohibit claims that supplements prevent, treat or cure disease. Incorrect classification, unsupported claims, ingredient deviations or inadequate stability data can delay launches, trigger relabeling and damage consumer trust. The risk is highest for digital-native brands scaling rapidly across novel botanicals, probiotics or condition-specific products without mature regulatory, quality and pharmacovigilance-style processes. **Data used:** Eight regulated functional-food categories; zero permitted disease-cure claims for health supplements **So what:** Regulatory affairs and quality systems should be treated as growth infrastructure rather than back-office compliance costs. #### Q: How does India compare with other major Asian nutraceutical markets? **A:** India ranks second among the selected peer markets by 2025 value, behind China and ahead of Japan, South Korea and Indonesia. India grows faster than these peers because its category penetration and per-capita spending remain lower, while its population scale, digital commerce and domestic ingredient capabilities create expansion capacity. China is substantially larger, while Japan offers higher per-capita spending and a mature functional-food framework. India's opportunity is therefore driven by penetration and formalization rather than mature-market replacement demand. **Data used:** India market value of USD 34,500 million in 2025; China market value of USD 98,230 million in 2025 **So what:** International entrants should localize pricing and formats instead of transferring mature-market portfolios without adaptation. #### Q: What demand factor provides the strongest long-term growth visibility? **A:** The strongest long-term demand factor is the convergence of chronic-disease risk, population aging and consumer movement toward preventive health. India had approximately 89.8 million adults with diabetes in 2024 and 107.98 million residents aged 65 or above in 2025. These cohorts support repeat demand for metabolic, cardiovascular, digestive, bone, muscle and general-wellness products. However, commercial success depends on affordability, credible evidence and distribution through trusted pharmacies, healthcare practitioners and established retail channels. **Data used:** 89.8 million adults with diabetes in 2024; 107.98 million people aged 65+ in 2025 **So what:** Portfolio strategy should prioritize recurring life-stage and condition-oriented needs with compliant, measurable consumer benefits. --- ## Table of Contents # CHAPTER 14 - Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases, Market Assessment, Go-To-Market Strategy, and Survey, delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. India Nutraceutical Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 India Nutraceutical Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. India Nutraceutical Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Preventive Health and Chronic-Disease Management ##### 3.1.2 Digital Commerce and Consumer Education ##### 3.1.3 Ingredient and Delivery-Format Innovation #### 3.2 Market Challenges ##### 3.2.1 Claims, Ingredient and Licensing Complexity ##### 3.2.2 Quality Consistency and Consumer Trust ##### 3.2.3 Affordability and Uneven Category Penetration #### 3.3 Market Opportunities ##### 3.3.1 Personalized Nutrition and Subscription Commerce ##### 3.3.2 Export-Oriented Ingredients and Contract Manufacturing ##### 3.3.3 Healthy-Aging and Metabolic Nutrition #### 3.4 Market Trends ##### 3.4.1 Condition-Specific Nutrition Portfolios ##### 3.4.2 Gummies, Powders and Convenient Delivery Formats ##### 3.4.3 Clean-Label Botanical Formulations ##### 3.4.4 Omnichannel Replenishment and Subscription Models #### 3.5 Government Regulation ##### 3.5.1 Food Safety and Standards Nutraceutical Classification ##### 3.5.2 Advertising and Health-Claims Compliance ##### 3.5.3 Novel Ingredient and Safe-Use Approval ##### 3.5.4 Labeling, Testing and Nutrient-Tolerance Requirements ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. India Nutraceutical Market Historical Size #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. India Nutraceutical Market Segmentation #### 8.1 Product Type ##### 8.1.1 Functional Foods ##### 8.1.2 Functional Beverages ##### 8.1.3 Dietary Supplements #### 8.2 Application ##### 8.2.1 General Wellness and Immunity ##### 8.2.2 Digestive Health ##### 8.2.3 Metabolic and Cardiovascular Health ##### 8.2.4 Bone and Joint Health ##### 8.2.5 Cognitive and Stress Support #### 8.3 End User ##### 8.3.1 Adults ##### 8.3.2 Children and Adolescents ##### 8.3.3 Older Adults ##### 8.3.4 Athletes and Fitness Consumers ##### 8.3.5 Pregnant and Lactating Women #### 8.4 Technology ##### 8.4.1 Botanical Extraction ##### 8.4.2 Fermentation and Probiotic Culturing ##### 8.4.3 Microencapsulation ##### 8.4.4 Liposomal Delivery ##### 8.4.5 Precision Nutrition Formulation #### 8.5 Price Tier ##### 8.5.1 Mass Market ##### 8.5.2 Mid-Premium ##### 8.5.3 Premium ##### 8.5.4 Clinical Premium #### 8.6 Distribution Channel ##### 8.6.1 Pharmacies and Drug Stores ##### 8.6.2 Grocery and Modern Trade ##### 8.6.3 Brand Direct E-Commerce ##### 8.6.4 Online Marketplaces ##### 8.6.5 Specialty Wellness Stores #### 8.7 Geography ##### 8.7.1 West India ##### 8.7.2 North India ##### 8.7.3 South India ##### 8.7.4 East and Northeast India ### 9. India Nutraceutical Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Product Portfolio Breadth ##### 9.2.4 Online and Pharmacy Distribution Reach ##### 9.2.5 India Nutraceutical Revenue Growth ##### 9.2.6 Gross Margin #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Amway India Enterprises Pvt Ltd ##### 9.5.2 Herbalife India Pvt Ltd ##### 9.5.3 Abbott India Ltd ##### 9.5.4 Himalaya Wellness Company ##### 9.5.5 Dabur India Ltd ##### 9.5.6 Patanjali Ayurved Ltd ##### 9.5.7 Bright Lifecare Pvt Ltd (HealthKart) ##### 9.5.8 Zydus Wellness Ltd ##### 9.5.9 Meyer Organics Pvt Ltd ##### 9.5.10 Baidyanath Group ### 10. India Nutraceutical Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Pharmacy Recommendation and Replenishment ##### 10.1.2 Consumer Ingredient and Claims Evaluation ##### 10.1.3 Subscription and Repeat-Purchase Behavior ##### 10.1.4 Institutional Nutrition Procurement #### 10.2 Corporate Spend Patterns ##### 10.2.1 Employee Wellness and Preventive Nutrition ##### 10.2.2 Sports and Fitness Partnership Spending ##### 10.2.3 Hospital and Clinical Nutrition Procurement ##### 10.2.4 Retailer Private-Label Development #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Product Authenticity and Ingredient Transparency ##### 10.3.2 Affordability and Monthly Regimen Cost ##### 10.3.3 Claims Credibility and Clinical Evidence ##### 10.3.4 Taste, Convenience and Adherence #### 10.4 User Readiness for Adoption ##### 10.4.1 Preventive-Health Awareness ##### 10.4.2 Digital Consultation Adoption ##### 10.4.3 Personalized Nutrition Willingness ##### 10.4.4 Premium Ingredient Acceptance #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Subscription Retention and Lifetime Value ##### 10.5.2 Cross-Selling Across Health Applications ##### 10.5.3 Pharmacy and Practitioner Referrals ##### 10.5.4 Export and Contract-Manufacturing Expansion ### 11. India Nutraceutical Market Future Size #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Healthy-Aging Nutrition Whitespace #### 1.2 Metabolic and Digestive-Health Niches #### 1.3 Personalized Subscription Models #### 1.4 Export-Oriented Formulation Opportunities ### 2. Marketing and Positioning Recommendations #### 2.1 Evidence-Led Benefit Communication #### 2.2 Life-Stage and Condition Positioning #### 2.3 Practitioner and Pharmacy Education #### 2.4 Regional Language Digital Content ### 3. Distribution Plan #### 3.1 Pharmacy Chain Partnerships #### 3.2 Brand Direct E-Commerce Rollout #### 3.3 Marketplace Assortment Strategy #### 3.4 Tier 2 and Tier 3 Distribution ### 4. Channel and Pricing Gaps #### 4.1 Affordable Monthly Regimen Packs #### 4.2 Pharmacy-Digital Price Alignment #### 4.3 Clinical Premium Justification #### 4.4 Subscription Discount Architecture ### 5. Unmet Demand and Latent Needs #### 5.1 Senior Muscle and Mobility Nutrition #### 5.2 Women's Life-Stage Nutrition #### 5.3 Region-Specific Botanical Formulations #### 5.4 Affordable Gut-Health Products ### 6. Customer Relationship #### 6.1 Replenishment Reminder Programs #### 6.2 Nutritionist-Led Consumer Support #### 6.3 Loyalty and Referral Programs #### 6.4 Adherence and Outcome Tracking ### 7. Value Proposition #### 7.1 Verified Ingredients and Transparent Claims #### 7.2 Convenient Daily Delivery Formats #### 7.3 Condition-Specific Product Architecture #### 7.4 Accessible Premium Nutrition ### 8. Key Activities #### 8.1 Regulatory Classification and Claims Review #### 8.2 Formulation and Stability Validation #### 8.3 Omnichannel Inventory Planning #### 8.4 Consumer Retention Analytics ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Select Priority Health Applications ##### 9.1.2 Validate Regulatory Classification ##### 9.1.3 Build Pharmacy and Digital Partnerships ##### 9.1.4 Scale Regional Manufacturing and Distribution #### 9.2 Export Entry Strategy ##### 9.2.1 Select Target Regulatory Markets ##### 9.2.2 Complete Ingredient and Claims Dossiers ##### 9.2.3 Establish International Quality Certifications ##### 9.2.4 Develop Distributor and Private-Label Partnerships ### 10. Entry Mode Assessment #### 10.1 Greenfield Manufacturing #### 10.2 Contract Manufacturing #### 10.3 Joint Venture with Domestic Brand #### 10.4 Acquisition of Digital-Native Specialist ### 11. Capital and Timeline Estimation #### 11.1 Formulation and Regulatory Investment #### 11.2 Manufacturing and Quality Infrastructure #### 11.3 Brand and Distribution Investment #### 11.4 Working-Capital and Inventory Requirements ### 12. Control vs Risk Trade-Off #### 12.1 Proprietary Manufacturing Control #### 12.2 Contract-Manufacturer Dependence #### 12.3 Marketplace Concentration Risk #### 12.4 Claims and Reputation Exposure ### 13. Profitability Outlook #### 13.1 Gross-Margin Potential by Product Type #### 13.2 Customer-Acquisition and Retention Economics #### 13.3 Channel Margin and Discount Leakage #### 13.4 Scale and Capacity-Utilization Benefits ### 14. Potential Partner List #### 14.1 Ingredient and Premix Suppliers #### 14.2 Contract Manufacturers #### 14.3 Pharmacy and Retail Chains #### 14.4 Digital Health and E-Commerce Platforms ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Complete Product and Claims Validation ##### 15.2.2 Launch Priority Digital and Pharmacy Channels ##### 15.2.3 Expand Portfolio and Regional Distribution ##### 15.2.4 Optimize Retention, Margin and Exports ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage, Priority Metros and Tier 2/3 Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1, Regular Adult Supplement Users ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2, Fitness and Performance Consumers ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3, Family and Life-Stage Buyers ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution #### 3.4 Cohort 4, Healthcare and Institutional Buyers ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Sectoral Growth Influences on Demand ##### 4.1.1 Income and Consumer Health-Spending Linkages ##### 4.1.2 Urbanization and Organized Retail Expansion ##### 4.1.3 Preventive-Health Investment and Purchase Timing ##### 4.1.4 Export and Import Dependency on India Nutraceutical Market #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Purchases ##### 4.2.2 Seasonal and Immunity-Led Demand Variations ##### 4.2.3 Brand Loyalty vs. Price Sensitivity Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Against Substitutes ##### 4.3.3 Regional Pricing Disparities ##### 4.3.4 Monthly Regimen Cost Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Quality Standards and Certification Requirements ##### 4.4.2 Safety and Regulatory Compliance Awareness ##### 4.4.3 Perception of Domestic vs. Imported Offerings ##### 4.4.4 Practitioner and Post-Purchase Support Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Regional Wellness Clusters and Demand Hotspots ##### 4.5.2 Ayurveda and Botanical Preference ##### 4.5.3 Peer, Trainer and Nutritionist Influence ##### 4.5.4 Digital Adoption and E-Pharmacy Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Impact of Wellness Events and Fitness Communities ##### 4.6.2 Role of Digital Marketing and Online Platforms ##### 4.6.3 Pharmacy and Distributor Influence on Purchase ##### 4.6.4 Healthcare Practitioner Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Identified Gaps Between Current Supply and User Expectations #### 5.2 Latent Demand in Underpenetrated Segments #### 5.3 Willingness to Adopt New Formats or Technologies #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us